Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenli Tao

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Foods (Basel, Switzerland)|September 13, 2025
Formation Mechanism of Characteristic Flavor Substances in 3-Year-Old Diannan Small-Ear Pig Ham: Lipidomics and Flavoromics StudyWenli Tao, Zhenzhu Li, Guangqiang Wei, et al.
Food Research International (Ottawa, Ont.)|November 21, 2025
GC-O-MS volatilomics combined lipidomics revealed the key volatile flavor compounds and their precursor in fermented cream driven by Lactiplantibacillus plantarum B22Yunmei Chai, Zhenzhu Li, Guangqiang Wei, et al.
Journal of Agricultural and Food Chemistry|September 17, 2025
Identification and Taste Presentation Characteristics of Umami Peptides from Hybrid Pork Duroc × (Gaoligongshan × Saba) Based on Peptidomics, Machine Learning, Molecular Docking, and Molecular Dynamics SimulationYuzhu Wang, Wentao Zheng, Daodian Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 3, 2015
Pharmacokinetics and Pharmacodynamics of the SGLT2 Inhibitor Remogliflozin Etabonate in Subjects with Mild and Moderate Renal ImpairmentRobin O'Connor-Semmes, Susan Walker, Anita Kapur, et al.
Molecules (Basel, Switzerland)|February 10, 2024
The Graphene Quantum Dots Gated Nanoplatform for Photothermal-Enhanced Synergetic Tumor TherapyLipin Wang, Wenbao Wang, Yufang Wang, et al.
Journal of Clinical Laboratory Analysis|April 15, 2025
A Large-Scale Retrospective Study of Serum Des-Gamma-Carboxy Prothrombin as a Diagnostic Marker of HCC: Effect of Liver Function on SpecificityHongying Bu, Weijia Luo, Wenli Tao, et al.
BMC Pharmacology & Toxicology|May 15, 2013
First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitusAnita Kapur, Robin O'Connor-Semmes, Elizabeth K Hussey, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 2, 2012
Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studiesJames F Sigafoos, Gary D Bowers, Stephen Castellino, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Foods (Basel, Switzerland)|September 13, 2025
Formation Mechanism of Characteristic Flavor Substances in 3-Year-Old Diannan Small-Ear Pig Ham: Lipidomics and Flavoromics StudyWenli Tao, Zhenzhu Li, Guangqiang Wei, et al.
Food Research International (Ottawa, Ont.)|November 21, 2025
GC-O-MS volatilomics combined lipidomics revealed the key volatile flavor compounds and their precursor in fermented cream driven by Lactiplantibacillus plantarum B22Yunmei Chai, Zhenzhu Li, Guangqiang Wei, et al.
Journal of Agricultural and Food Chemistry|September 17, 2025
Identification and Taste Presentation Characteristics of Umami Peptides from Hybrid Pork Duroc × (Gaoligongshan × Saba) Based on Peptidomics, Machine Learning, Molecular Docking, and Molecular Dynamics SimulationYuzhu Wang, Wentao Zheng, Daodian Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 3, 2015
Pharmacokinetics and Pharmacodynamics of the SGLT2 Inhibitor Remogliflozin Etabonate in Subjects with Mild and Moderate Renal ImpairmentRobin O'Connor-Semmes, Susan Walker, Anita Kapur, et al.
Molecules (Basel, Switzerland)|February 10, 2024
The Graphene Quantum Dots Gated Nanoplatform for Photothermal-Enhanced Synergetic Tumor TherapyLipin Wang, Wenbao Wang, Yufang Wang, et al.
Journal of Clinical Laboratory Analysis|April 15, 2025
A Large-Scale Retrospective Study of Serum Des-Gamma-Carboxy Prothrombin as a Diagnostic Marker of HCC: Effect of Liver Function on SpecificityHongying Bu, Weijia Luo, Wenli Tao, et al.
BMC Pharmacology & Toxicology|May 15, 2013
First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitusAnita Kapur, Robin O'Connor-Semmes, Elizabeth K Hussey, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 2, 2012
Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studiesJames F Sigafoos, Gary D Bowers, Stephen Castellino, et al.
Pageof 2